Literature DB >> 9884187

Analytical techniques used to study the degradation of proteins and peptides: chemical instability.

J L Reubsaet1, J H Beijnen, A Bult, R J van Maanen, J A Marchal, W J Underberg.   

Abstract

Instability of peptides and proteins can be divided into two forms: chemical and physical instability. Chemical instability is due to modification/alteration of amino acid residues. There are several types of degradation reactions responsible for this instability. Most frequently described reactions are oxidation, reduction, deamidation, hydrolysis, arginine conversion, beta-elimination and racemisation. However, any study of the degradation of a chemical substance lacks reliability when the analytical methodology, that is used is not properly validated. Especially in the investigation, where degradation processes lead to their parent compounds, validation of the analysis is pivotal for the correct interpretation of the results. It is therefore appropriate and useful to assemble an overview of degradation processes in relation to the analytical methods to monitor them. An overview like this can help investigators to make the right choices in their analytical approach of stability problems. The degradation reactions involved in peptide/protein degradation as well as the methods to monitor them are summarized and discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884187     DOI: 10.1016/s0731-7085(98)00063-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 2.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

3.  FTIR markers of methionine oxidation for early detection of oxidized protein therapeutics.

Authors:  Jascindra Ravi; Anna E Hills; Eleonora Cerasoli; Paulina D Rakowska; Maxim G Ryadnov
Journal:  Eur Biophys J       Date:  2011-01-13       Impact factor: 1.733

4.  Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the oral cavity.

Authors:  Dong Hee Na; Jabar Faraj; Yilmaz Capan; Kai P Leung; Patrick P DeLuca
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

5.  Identification and characterization of sulfated glycoproteins from small cell lung carcinoma cells assisted by management of molecular charges.

Authors:  Masaaki Toyoda; Hiroyuki Kaji; Hiromichi Sawaki; Akira Togayachi; Takashi Angata; Hisashi Narimatsu; Akihiko Kameyama
Journal:  Glycoconj J       Date:  2016-06-18       Impact factor: 2.916

6.  High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants.

Authors:  Danielle M DiCara; Nisana Andersen; Ruby Chan; James A Ernst; Gai Ayalon; Greg A Lazar; Nicholas J Agard; Amy Hilderbrand; Isidro Hötzel
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

7.  Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles.

Authors:  Christopher P Calderon; Ana Krhač Levačić; Constanze Helbig; Klaus Wuchner; Tim Menzen
Journal:  J Pharm Sci       Date:  2022-06-01       Impact factor: 3.784

8.  Citropin 1.1 Trifluoroacetate to Chloride Counter-Ion Exchange in HCl-Saturated Organic Solutions: An Alternative Approach.

Authors:  Karol Sikora; Damian Neubauer; Maciej Jaśkiewicz; Wojciech Kamysz
Journal:  Int J Pept Res Ther       Date:  2017-07-12       Impact factor: 1.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.